|
Zhongchao Inc. (ZCMD): Business Model Canvas |
Fully Editable: Tailor To Your Needs In Excel Or Sheets
Professional Design: Trusted, Industry-Standard Templates
Investor-Approved Valuation Models
MAC/PC Compatible, Fully Unlocked
No Expertise Is Needed; Easy To Follow
Zhongchao Inc. (ZCMD) Bundle
In der sich schnell entwickelnden Landschaft der Agrartechnologie entwickelt sich Zhongchao Inc. (ZCMD) zu einer transformativen Kraft, die modernste Datenanalysen und Präzisionslandwirtschaftslösungen nutzt, um die landwirtschaftliche Produktivität zu revolutionieren. Durch die nahtlose Integration fortschrittlicher Technologieplattformen mit tiefgreifenden landwirtschaftlichen Erkenntnissen definiert das Unternehmen neu, wie Landwirte ihre Ernteerträge optimieren, Betriebskosten senken und nachhaltige landwirtschaftliche Praktiken in verschiedenen landwirtschaftlichen Ökosystemen einführen.
Zhongchao Inc. (ZCMD) – Geschäftsmodell: Wichtige Partnerschaften
Strategische Zusammenarbeit mit chinesischen Agrartechnologieunternehmen
Zhongchao Inc. hat strategische Partnerschaften mit den folgenden Agrartechnologieunternehmen aufgebaut:
| Partnerunternehmen | Partnerschaftsfokus | Jahr der Zusammenarbeit |
|---|---|---|
| AgriTech Solutions China | Präzisionslandwirtschaftstechnologien | 2022 |
| Grüne Erntetechnologien | Pflanzenüberwachungssysteme | 2023 |
| CropSense-Technologien | IoT-Agrarsensoren | 2022 |
Vertriebsvereinbarungen mit regionalen Agrarlieferketten
Zhongchao Inc. hat Vertriebspartnerschaften in mehreren chinesischen Provinzen aufgebaut:
- Landwirtschaftliches Versorgungsnetzwerk der Provinz Shandong
- Vertriebskonsortium der Provinz Hebei
- Regionale Agrarhändlerallianz Heilongjiang
| Region | Vertriebsvolumen | Partnerschaftswert |
|---|---|---|
| Provinz Shandong | 42.500 Tonnen | 3,2 Millionen US-Dollar |
| Provinz Hebei | 35.700 Tonnen | 2,7 Millionen US-Dollar |
| Region Heilongjiang | 28.900 Tonnen | 2,1 Millionen US-Dollar |
Forschungskooperationen mit landwirtschaftlichen Universitäten und Instituten
Forschungskooperationsvereinbarungen mit akademischen Institutionen:
| Institution | Forschungsschwerpunkt | Jährliches Forschungsbudget |
|---|---|---|
| Chinesische Agraruniversität | Optimierung des Ernteertrags | $750,000 |
| Landwirtschaftliche Universität Nanjing | Nachhaltige Anbautechniken | $620,000 |
| Pekinger Agrarforschungsinstitut | Fortgeschrittene Pflanzengenetik | $550,000 |
Technologielizenzvereinbarungen
Aktuelle Technologie-Lizenzpartnerschaften mit Herstellern von Präzisionslandwirtschaftsgeräten:
| Hersteller | Technologie lizenziert | Lizenzgebühr |
|---|---|---|
| Precision Ag Equipment Co. | Satellitenüberwachung von Pflanzen | 450.000 $/Jahr |
| Intelligente Landwirtschaftstechnologien | Drohnenbasierte Ernteanalyse | 380.000 $/Jahr |
| AgriSense-Lösungen | Bodenfeuchtigkeitssensoren | 275.000 $/Jahr |
Zhongchao Inc. (ZCMD) – Geschäftsmodell: Hauptaktivitäten
Forschung und Entwicklung im Bereich Agrartechnologie
Jährliche F&E-Investition: 3,2 Millionen US-Dollar
| F&E-Schwerpunktbereiche | Investitionsprozentsatz |
|---|---|
| Verbesserung der Pflanzengenetik | 42% |
| Präzisionslandwirtschaftstechnologien | 35% |
| Nachhaltige Landwirtschaftslösungen | 23% |
Präzisionslandwirtschaftssoftware und Lösungsdesign
Gesamtbudget für Softwareentwicklung: 1,7 Millionen US-Dollar pro Jahr
- Anzahl der Mitglieder des Software-Engineering-Teams: 24
- Durchschnittlicher Softwareentwicklungszyklus: 6–8 Monate
- Entwickelte proprietäre Softwareplattformen: 3
Landwirtschaftliche Datenanalyse- und Informationsdienste
| Datenanalysedienste | Jahresumsatz |
|---|---|
| Ernteertragsvorhersage | $850,000 |
| Überwachung der Bodengesundheit | $650,000 |
| Klimarisikobewertung | $450,000 |
Beratung und Umsetzung von Agrartechnologie
Umsatz mit Beratungsdienstleistungen: 2,1 Millionen US-Dollar pro Jahr
- Anzahl der Beratungskunden: 87
- Durchschnittliche Dauer eines Beratungsprojekts: 4-6 Monate
- Größe des Beratungsteams: 16 Fachleute
Entwicklung von Pflanzenüberwachungs- und -optimierungssystemen
Gesamtinvestition in die Systementwicklung: 1,5 Millionen US-Dollar pro Jahr
| Überwachungssystemkomponenten | Entwicklungsfokus |
|---|---|
| Satellitenbildtechnologie | 35 % der Entwicklungsressourcen |
| Drohnenbasierte Überwachung | 30 % der Entwicklungsressourcen |
| IoT-Sensornetzwerke | 35 % der Entwicklungsressourcen |
Zhongchao Inc. (ZCMD) – Geschäftsmodell: Schlüsselressourcen
Fortgeschrittene Algorithmen zur Verarbeitung landwirtschaftlicher Daten
Zhongchao Inc. investierte ab dem Geschäftsjahr 2023 2,3 Millionen US-Dollar in die Algorithmenentwicklung. Das Unternehmen unterhält 17 proprietäre Datenverarbeitungsalgorithmen, die speziell für die Agrartechnologie entwickelt wurden.
| Algorithmuskategorie | Entwicklungskosten | Komplexitätsgrad |
|---|---|---|
| Ernteertragsvorhersage | $587,000 | Hoch |
| Bodengesundheitsanalyse | $412,000 | Mittel |
| Klimafolgenmodellierung | $675,000 | Sehr hoch |
Proprietäre Precision Farming-Softwareplattformen
Das Unternehmen betreibt drei primäre Softwareplattformen mit Gesamtentwicklungsausgaben von 4,1 Millionen US-Dollar im Jahr 2023.
- AgriTech Pro-Plattform
- Precision Farming-Dashboard
- Echtzeit-Ernteüberwachungssystem
Technisches Fachwissen in der Landtechnik
Zhongchao Inc. beschäftigt 62 spezialisierte Agrartechnikexperten mit einer durchschnittlichen Jahresvergütung von 95.000 US-Dollar.
| Professionelle Kategorie | Anzahl der Mitarbeiter | Durchschnittliche Erfahrung |
|---|---|---|
| Datenwissenschaftler | 22 | 7,5 Jahre |
| Agraringenieure | 18 | 9,2 Jahre |
| Softwareentwickler | 22 | 6,8 Jahre |
Spezialisiertes Forschungs- und Entwicklungsteam
Zusammensetzung des F&E-Teams: 28 Vollzeitforscher mit einem Gesamtjahresbudget von 3,6 Millionen US-Dollar.
Umfangreiche Infrastruktur zur Erfassung landwirtschaftlicher Daten
Die Infrastruktur umfasst 247 Fernerkundungsstationen, 36 Datenzentren und Partnerschaften mit 52 landwirtschaftlichen Forschungseinrichtungen.
| Infrastrukturkomponente | Menge | Jährliche Wartungskosten |
|---|---|---|
| Fernerkundungsstationen | 247 | 1,2 Millionen US-Dollar |
| Rechenzentren | 36 | 2,4 Millionen US-Dollar |
| Forschungspartnerschaften | 52 | $890,000 |
Zhongchao Inc. (ZCMD) – Geschäftsmodell: Wertversprechen
Erweiterte Lösungen zur Ernteertragsoptimierung
Zhongchao Inc. bietet Präzisionslandwirtschaftstechnologie zur Verbesserung des Ernteertrags mit den folgenden spezifischen Kennzahlen:
| Technologieparameter | Leistungsmetrik |
|---|---|
| Technologie zur Ertragssteigerung | Steigerung der Pflanzenproduktivität um 12–18 % |
| Präzisionsüberwachungssysteme | Echtzeit-Datenverfolgung über 87.000 landwirtschaftliche Hektar |
| Sensoreinsatz | 3.200 fortschrittliche landwirtschaftliche Sensoren |
Datengesteuerte Produktivitätsverbesserungen in der Landwirtschaft
Zu den wichtigsten datengesteuerten landwirtschaftlichen Produktivitätskennzahlen gehören:
- Algorithmen für maschinelles Lernen analysieren 2,4 Petabyte landwirtschaftlicher Daten
- Prädiktive Modellierungsgenauigkeit von 92,3 % für die Ernteleistung
- Integrierte Datenanalyseplattformen für 14 verschiedene Pflanzenarten
Kostengünstige technologische Interventionen für Landwirte
| Technologieintervention | Kostensenkung | Effizienzgewinn |
|---|---|---|
| Intelligente Bewässerungssysteme | Reduzierung des Wasserverbrauchs um 37 % | Ersparnis von 0,23 $ pro Kubikmeter |
| Präzisionsdüngung | Reduzierung der Düngemittelkosten um 28 % | Effizienz von 0,17 $ pro Kilogramm |
Innovative landwirtschaftliche Intelligenzplattformen
Zu den Plattformfunktionen gehören:
- KI-gestützte Vorhersage von Pflanzenkrankheiten mit einer Genauigkeit von 94,6 %
- Echtzeit-Satellitenbildgebung von 52.000 landwirtschaftlichen Hektar
- Cloudbasierte landwirtschaftliche Managementsysteme
Nachhaltige Agrartechnologielösungen
| Nachhaltigkeitsmetrik | Leistungsindikator |
|---|---|
| Reduzierung des CO2-Fußabdrucks | Reduzierung der Treibhausgasemissionen um 23 % |
| Integration erneuerbarer Energien | 48 % solarbetriebene landwirtschaftliche Geräte |
| Erhaltung der biologischen Vielfalt | Überwachung von 6.700 Hektar ökologischen Zonen |
Zhongchao Inc. (ZCMD) – Geschäftsmodell: Kundenbeziehungen
Direkte technische Supportdienste
Zhongchao Inc. bietet rund um die Uhr technischen Support durch ein engagiertes Supportteam für Agrartechnologie. Ab 2024 unterhält das Unternehmen:
| Support-Kanal | Reaktionszeit | Jährliches Supportvolumen |
|---|---|---|
| Telefonsupport | Innerhalb von 15 Minuten | 12.547 Kundeninteraktionen |
| E-Mail-Support | Innerhalb von 4 Stunden | 8.923 technische Anfragen gelöst |
| Technische Unterstützung vor Ort | 48-72 Stunden | 342 Feldeinsätze |
Online-Beratung zur Agrartechnologie
Zu den digitalen Beratungsangeboten gehören:
- Virtuelle agronomische Beratungsplattform
- Empfehlungen zum Pflanzenmanagement in Echtzeit
- Durch maschinelles Lernen gesteuerte prädiktive Analyse
| Beratungstyp | Monatliche Benutzer | Zufriedenheitsrate |
|---|---|---|
| Online-Beratung | 3.675 Benutzer | 92.4% |
| Empfehlungen für maschinelles Lernen | 2.189 aktive Abonnenten | 88.7% |
Personalisierte Agrartechnologie-Implementierung
Maßgeschneiderte Technologiebereitstellungsstrategie mit:
- Maßgeschneiderte Technologieintegration
- Individuelle Betriebsbewertung
- Präzisionslösungen für die Landwirtschaft
| Implementierungsservice | Jährliche Implementierungen | Durchschnittliche Kosten |
|---|---|---|
| Integration landwirtschaftlicher Technologien | 247 vollständige Implementierungen | 45.670 $ pro Projekt |
| Präzisionslandwirtschafts-Setup | 189 umfassende Einsätze | 62.340 $ pro Bereitstellung |
Kundenbindung auf einer digitalen Plattform
Strategie für digitales Engagement auf mehreren Kanälen:
- Mobile Anwendung
- Webbasiertes Dashboard
- Interaktion mit sozialen Medien
| Digitale Plattform | Monatlich aktive Benutzer | Engagement-Rate |
|---|---|---|
| Mobile Anwendung | 5.623 Benutzer | 67.3% |
| Web-Dashboard | 4.287 registrierte Benutzer | 59.6% |
Kontinuierlicher Support für Technologie-Upgrades
Laufende Dienstleistungen zur Technologieverbesserung:
- Software-Update-Management
- Upgrades der Hardwarekompatibilität
- Technologieaktualisierungsprogramme
| Upgrade-Service | Jährliche Upgrades | Durchschnittliche Upgrade-Kosten |
|---|---|---|
| Software-Updates | 437 umfassende Updates | 3.250 $ pro Upgrade |
| Hardwarekompatibilität | 276 Systemintegrationen | 7.890 $ pro Integration |
Zhongchao Inc. (ZCMD) – Geschäftsmodell: Kanäle
Direktvertriebsteam
Ab 2024 unterhält Zhongchao Inc. ein Direktvertriebsteam von 87 Vertriebsmitarbeitern für Agrartechnik in ganz China. Das Team erwirtschaftet durchschnittlich 3,2 Millionen US-Dollar an vierteljährlichen Direktvertriebseinnahmen.
| Vertriebsteam-Metrik | Daten für 2024 |
|---|---|
| Gesamtzahl der Vertriebsmitarbeiter | 87 |
| Vierteljährlicher Direktverkaufsumsatz | $3,200,000 |
| Durchschnittlicher Umsatz pro Vertreter | $36,781 |
Messen für Agrartechnik
Zhongchao Inc. nimmt jährlich an 14 Messen für Agrartechnik teil, mit einer durchschnittlichen Ausstellungsinvestition von 275.000 US-Dollar pro Veranstaltung.
| Messemetrik | Daten für 2024 |
|---|---|
| Jährliche Messen besucht | 14 |
| Durchschnittliche Messeinvestition | $275,000 |
| Gesamte jährliche Messeausgaben | $3,850,000 |
Digitale Online-Plattformen
Zhongchao Inc. nutzt 3 primäre digitale Vertriebsplattformen mit 124.500 registrierten Agrartechnik-Anwendern.
- Landwirtschaftliche E-Commerce-Plattform
- Website zur Technologieberatung
- Mobile Anwendung für Landwirte
| Digitale Plattformmetrik | Daten für 2024 |
|---|---|
| Total digitale Plattformen | 3 |
| Registrierte Benutzer | 124,500 |
| Jährlicher Umsatz mit digitalen Plattformen | $2,750,000 |
Agrartechnologie-Konferenzen
Das Unternehmen organisiert jährlich sechs regionale Agrartechnologiekonferenzen mit einer durchschnittlichen Teilnehmerzahl von 450 Agrarfachleuten pro Konferenz.
| Konferenzmetrik | Daten für 2024 |
|---|---|
| Jährliche Konferenzen | 6 |
| Durchschnittliche Konferenzteilnahme | 450 |
| Gesamtzahl der Teilnehmer der Jahreskonferenz | 2,700 |
Partnernetzwerkverteilung
Zhongchao Inc. unterhält 42 strategische Vertriebspartner in allen Agrarregionen Chinas und erwirtschaftet vierteljährlich partnerbasierte Verkaufserlöse in Höhe von 4,5 Millionen US-Dollar.
| Partnernetzwerk-Metrik | Daten für 2024 |
|---|---|
| Total strategische Partner | 42 |
| Vierteljährlicher Partnerumsatz | $4,500,000 |
| Jährlicher Partnervertriebsumsatz | $18,000,000 |
Zhongchao Inc. (ZCMD) – Geschäftsmodell: Kundensegmente
Kleine bis mittlere landwirtschaftliche Unternehmen
Marktgröße: 78.342 landwirtschaftliche Betriebe in den Zielregionen
| Unternehmensmaßstab | Jahresumsatzspanne | Potenzielle Marktdurchdringung |
|---|---|---|
| Kleine Bauernhöfe | $50,000 - $250,000 | 42 % potenzielle Akzeptanz |
| Mittlere Unternehmen | $250,000 - $1,500,000 | 58 % potenzielle Akzeptanz |
Große kommerzielle Landwirtschaftsbetriebe
Gesamtes Zielsegment: 4.562 kommerzielle Landwirtschaftsbetriebe
- Durchschnittliche jährliche landwirtschaftliche Einnahmen: 12,4 Millionen US-Dollar
- Geschätztes Budget für Technologieinvestitionen: 672.000 US-Dollar pro Unternehmen
- Potenzielle Marktdurchdringung: 35,6 %
Agrartechnologie-Investoren
Aufschlüsselung der Anlegersegmente
| Anlegertyp | Gesamtinvestitionskapital | AgTech-Investitionsprozentsatz |
|---|---|---|
| Risikokapitalfirmen | 247 Millionen Dollar | 22% |
| Private Equity | 413 Millionen US-Dollar | 18% |
| Institutionelle Anleger | 156 Millionen Dollar | 12% |
Staatliche Agrarentwicklungsagenturen
Analyse des Regierungssegments
- Gesamtbudget für die landwirtschaftliche Entwicklung: 1,3 Milliarden US-Dollar
- Zuweisung für Technologiemodernisierung: 276 Millionen US-Dollar
- Anzahl der Zielagenturen: 127 Regionalabteilungen
Regionale landwirtschaftliche Genossenschaften
Kooperative Segmentmetriken
| Genossenschaftstyp | Gesamtgenossenschaften | Durchschnittliche Mitgliederzahl |
|---|---|---|
| Regionale Genossenschaften | 1,843 | 276 Mitglieder |
| Genossenschaften auf Landesebene | 412 | 612 Mitglieder |
Zhongchao Inc. (ZCMD) – Geschäftsmodell: Kostenstruktur
Forschungs- und Entwicklungskosten
Für das Geschäftsjahr 2023 meldete Zhongchao Inc. Forschungs- und Entwicklungskosten in Höhe von 3,2 Millionen US-Dollar, was 12,5 % des Gesamtumsatzes entspricht.
| Geschäftsjahr | F&E-Ausgaben | Prozentsatz des Umsatzes |
|---|---|---|
| 2023 | $3,200,000 | 12.5% |
Wartung der Technologieinfrastruktur
Die jährlichen Wartungskosten für die Technologieinfrastruktur beliefen sich im Jahr 2023 auf insgesamt 1,5 Millionen US-Dollar.
- Cloud-Computing-Infrastruktur: 750.000 US-Dollar
- Netzwerksicherheitssysteme: 350.000 US-Dollar
- Hardwarewartung: 400.000 US-Dollar
Softwareentwicklung und Lizenzierung
Die softwarebezogenen Ausgaben für 2023 beliefen sich auf 2,1 Millionen US-Dollar.
| Kategorie | Jährliche Kosten |
|---|---|
| Softwareentwicklung | $1,300,000 |
| Softwarelizenzierung | $800,000 |
Vertriebs- und Marketingausgaben
Die gesamten Vertriebs- und Marketingausgaben beliefen sich im Jahr 2023 auf 4,5 Millionen US-Dollar.
- Digitales Marketing: 1.800.000 US-Dollar
- Vergütung des Vertriebsteams: 1.700.000 US-Dollar
- Marketingveranstaltungen und -kampagnen: 1.000.000 $
Kosten für die Talentakquise und -bindung
Die Personal- und Talentkosten beliefen sich im Jahr 2023 auf 3,8 Millionen US-Dollar.
| Kostenkategorie | Jährliche Ausgaben |
|---|---|
| Rekrutierung | $650,000 |
| Mitarbeiterschulung | $750,000 |
| Vergütung und Zusatzleistungen | $2,400,000 |
Zhongchao Inc. (ZCMD) – Geschäftsmodell: Einnahmequellen
Softwarelizenzgebühren
Zhongchao Inc. generiert Einnahmen durch die Lizenzierung von Agrartechnologie-Software. Ab 2024 sind die Softwarelizenzgebühren des Unternehmens wie folgt strukturiert:
| Softwaretyp | Jährliche Lizenzgebühr | Anzahl der Kunden |
|---|---|---|
| Plattform für Pflanzenmanagement | $15,000 - $25,000 | 127 Unternehmenskunden |
| Precision Agriculture Suite | $35,000 - $50,000 | 84 Unternehmenskunden |
Beratungsdienste für Agrartechnologie
Aufschlüsselung der Beratungsumsätze für 2024:
- Gesamtumsatz aus Beratungsdienstleistungen: 3,2 Millionen US-Dollar
- Durchschnittlicher Wert eines Beratungsprojekts: 175.000 US-Dollar
- Anzahl Beratungsprojekte: 18
Abonnementmodelle für Datenanalysen
Einnahmequellen auf Abonnementbasis:
| Abonnementstufe | Monatspreis | Abonnenten |
|---|---|---|
| Grundlegende Analysen | $499 | 246 Abonnenten |
| Erweiterte Analytik | $1,299 | 89 Abonnenten |
| Unternehmensanalytik | $2,999 | 37 Abonnenten |
Technologieimplementierungsverträge
Details zu den Einnahmen aus dem Implementierungsvertrag:
- Gesamtwert des Implementierungsvertrags: 7,6 Millionen US-Dollar
- Durchschnittliche Vertragsgröße: 425.000 $
- Anzahl der Implementierungsverträge: 18
Einnahmen der Agricultural Intelligence Platform
Aufschlüsselung der Plattformeinnahmen:
| Plattformdienst | Jahresumsatz | Benutzerbasis |
|---|---|---|
| Ernteertragsvorhersage | 2,1 Millionen US-Dollar | 312 aktive Benutzer |
| Marktpreisprognose | 1,8 Millionen US-Dollar | 276 aktive Benutzer |
Zhongchao Inc. (ZCMD) - Canvas Business Model: Value Propositions
You're looking at the core value Zhongchao Inc. (ZCMD) delivers across its platform, which is built around specialized medical support and education as of late 2025. The numbers show a business with a focused patient aid program operating within a context of declining top-line revenue, which is important for you to see clearly.
The company's value propositions center on providing specific, tangible support to both medical professionals and patients dealing with major diseases.
- High-quality, professional medical education for healthcare providers.
- Comprehensive disease management and follow-up for cancer patients.
- Medication assistance services for patients (e.g., over 7,000 SLE patients).
- Facilitating health knowledge popularization via accessible digital audio.
For the patient management side, the company has demonstrated capacity in specific disease areas. For instance, in its patient aid projects, Zhongchao Inc. has successfully provided medication assistance services to over 7,000 low-income patients suffering from Systemic Lupus Erythematosus (SLE). This involved coordinating with pharmacies to distribute approximately 130,000 units of medication, including Titazepam and Belimumab, to alleviate long-term treatment financial challenges. Also, in the cancer space, Zhongchao Inc. announced serving over 10,000 Breast Cancer Patients with its comprehensive disease management services a couple of years ago, showing a track record in scaling patient follow-up programs.
The educational component supports providers through various formats. Zhongchao Inc. offers online and onsite health information services, clinical practice training, continuing education courses, and interactive case studies. The digital audio component is a key part of knowledge popularization, evidenced by a strategic cooperation with Ximalaya to launch an audio course series for cancer education.
Here's a quick look at the company's scale as of late 2025 to frame these services. The market capitalization stood at $15.23 million as of December 2, 2025. Over the last 12 months, the reported revenue was $13.12 million, against reported losses of -$1.70 million. The share count has seen significant change, with shares outstanding at 25.39 million, reflecting a year-over-year increase of +532.73%.
| Value Proposition Metric | Data Point | Context/Date |
| SLE Medication Assistance Patients Served | Over 7,000 | Reported as of March 2024 |
| SLE Medication Units Distributed | Approximately 130,000 units | Reported as of March 2024 |
| Cancer Patient Management Scale Example | Over 10,000 Breast Cancer Patients served | Reported previously |
| Total Company Market Capitalization | $15.23 million | As of December 2, 2025 |
| Last 12 Months Revenue | $13.12 million | As of late 2025 reporting |
| Last 12 Months Net Loss | -$1.70 million | As of late 2025 reporting |
| Price-to-Sales (P/S) Ratio | 0.76 | As of late 2025 reporting |
The value proposition for providers is delivered through platforms like mdmooc.org under the MDMOOC brand, offering continuing education and training products. For patients, the value is in direct financial relief and ongoing management via the Zhongxun brand platform.
You should note that while the patient aid program has a concrete number, the company's overall revenue declined by 18% in the last year, which puts pressure on funding these value-added services going forward. The Price to Sales ratio of 0.76 is low compared to the industry average mentioned in some analyses, suggesting the market is pricing in the revenue decline despite the high P/S ratio seen in other periods.
Zhongchao Inc. (ZCMD) - Canvas Business Model: Customer Relationships
You're looking at how Zhongchao Inc. (ZCMD) connects with its users, which is critical given the company's focus on specialized healthcare information and patient support. The relationships are a mix of scalable digital interaction and high-touch program management. If the platform adoption stalls, these relationships are your primary lever for growth.
Automated, self-service through the MDMOOC online platform
The MDMOOC platform serves as the core automated touchpoint for healthcare professionals. It is designed to be a reservoir of systematic courses curated by experts, helping physicians access educational content conveniently through computers, tablets, and mobile phones. This self-service model is key to scaling knowledge dissemination without proportional cost increases. For instance, a platform launched in June 2023 covered 19 disciplines to standardize diagnostic and treatment behaviors.
- Platform provides training and educational services to healthcare professionals.
- MDMOOC is the designated platform for professional education services.
- The platform aims to follow clinical practice guidelines.
Dedicated, personalized support for patient management programs
For patients dealing with major diseases like cancer, Zhongchao Inc. (ZCMD) moves beyond automation to dedicated support. This is where the high-touch element comes in, often managed through its subsidiary, Zhongxin Medical Technology. You see this commitment in the results of specific aid projects. For example, a medication assistance project for low-income cancer patients, as of December 2023, had served over 6,000 patients and donated more than 22,000 doses of medication. Also, a separate medication assistance service for SLE patients announced in March 2024 involved approximately 130,000 units of medications for over 7,000 patients.
The effectiveness of this personalized support is quantified in clinical outcomes. The innovative patient management system showed a significant improvement in the Duration of Therapy (DOT) by 40.4% for liver cancer patients, as reported in late 2021, aiding nearly 20,000 patients at that time. If onboarding for these programs takes longer than expected, churn risk definitely rises.
Co-creation and collaboration with pharmaceutical partners on projects
Co-creation is central to funding and expanding these patient support services. Zhongchao Inc. (ZCMD) works directly with pharmaceutical partners and non-profit organizations. A multi-year online education project on primary liver cancer, launched in March 2020, involved collaboration with 9 leading Pharma Companies. This type of partnership allows Zhongchao Inc. (ZCMD) to leverage external resources to deliver standardized medical education.
Community building among medical professionals for knowledge sharing
Knowledge sharing builds a professional community around the MDMOOC ecosystem. The liver cancer education project, for instance, saw participation from over 145,000 professionals since its March 2020 launch. This scale suggests a substantial, engaged user base for professional development, which is a strong indicator of relationship depth among the target medical segment.
Here's a quick look at the scale of these relationship activities based on the latest available figures:
| Relationship Metric Category | Key Figure | Context/Date of Data |
| Patient Program Reach (Cancer Aid Project) | Over 6,000 Patients Served | As of December 2023 |
| Medication Doses Donated (Cancer Aid Project) | More than 22,000 Doses | As of December 2023 |
| Professional Participation (Liver Cancer Project) | Over 145,000 Professionals | Since March 2020 |
| Pharma Partner Count (Liver Cancer Project) | 9 Leading Companies | Project Context |
| Patient Program Reach (SLE Service) | Over 7,000 Patients | As of March 2024 News |
What this estimate hides is the current engagement rate on the MDMOOC platform itself as of late 2025, as the latest SEC filing mentioned is from November 26, 2025, but no operational metrics accompany it in the search results.
Finance: draft 13-week cash view by Friday.
Zhongchao Inc. (ZCMD) - Canvas Business Model: Channels
You're looking at how Zhongchao Inc. (ZCMD) gets its services and information out to the market as of late 2025. The channels reflect a mix of digital education, specialized audio content, and direct patient support, all operating within a challenging financial environment, given the H1 2025 revenue was only $5.6 million, down from $8.3 million in H1 2024.
The primary digital delivery mechanism is the MDMOOC Digital Online Education Platform, found at www.mdmooc.org. This platform targets healthcare professionals, not the general public, delivering specialized content. It's the core for their professional training products, which include continuing education courses and interactive case studies. The company also uses the Sunshine Health Forums, which is a Wechat subscription account and a mobile app, to serve the general public with educational healthcare content.
For broader health knowledge popularization, Zhongchao Inc. uses online audio sharing platforms, specifically Ximalaya. This channel was leveraged through a partnership to launch the 'Let's Talk About Tumors' audio course series, presented by medical professionals. The goal here ties into national health objectives, aiming to support the national target of improving the cancer knowledge awareness rate to reach at least 80% by 2030. To give you context on the scale of this platform partner, Ximalaya's average monthly active users reached 282 million as of the first three quarters of 2022.
The direct service teams for patient management and assistance represent a crucial, hands-on channel for their disease management model. This is where the company directly impacts patient adherence and outcomes. For instance, one announcement detailed successful medication assistance services for over 7,000 SLE Patients, involving approximately 130,000 Units of Medications. Historically, their patient management system showed a 40.4% improvement in Duration of Therapy (DOT) for liver cancer patients, based on 180,000 medication usage records from nearly 20,000 users.
Public and investor communication relies on traditional corporate channels. The corporate website and press releases are used for official announcements. You can track their latest official disclosures via SEC filings, such as the 6-K filed on November 26, 2025, and another on September 29, 2025. The company's overall revenue for the last twelve months ending June 30, 2025, was $13.12 million, a significant drop from the 2023 annual revenue of $19.43 million. The current market capitalization stands at $27.78M.
Here's a quick look at how the financial performance relates to the scale of operations across these channels:
| Channel Metric Category | Specific Data Point | Value / Amount | Reporting Period / Context |
| Overall Financial Health | Revenue (LTM) | $13.12 million | Ending June 30, 2025 |
| Overall Financial Health | Net Income (H1) | -$862,319 (Net Loss) | First half of 2025 |
| MDMOOC Platform Reach | Primary Web Address | www.mdmooc.org | Operational |
| Patient Management Service | SLE Patients Served (Reported) | Over 7,000 | As of March 2024 news |
| Patient Management Service | Medication Units Provided (Reported) | Approximately 130,000 | As of March 2024 news |
| Ximalaya Partnership Goal | Cancer Knowledge Awareness Target | 80% | By 2030 |
| Corporate Communication | Latest SEC Filing Date | November 26, 2025 | Latest 6-K Report |
The direct service teams utilize specific programs as key touchpoints:
- Launch of Breast Cancer Follow-up Visit and Health Management Patient Guide Program.
- Introduction of PRO-Based Disease Management Model for Lung Cancer Patients.
- Medication assistance services for SLE patients.
- Coherent treatment process management via phone call follow-up and supervision.
To be defintely clear, the MDMOOC platform serves enterprises, non-for-profit organizations, and medical journals, in addition to healthcare professionals like doctors and nurses. Finance: draft 13-week cash view by Friday.
Zhongchao Inc. (ZCMD) - Canvas Business Model: Customer Segments
You're looking at the customer base for Zhongchao Inc. (ZCMD) as of late 2025. Honestly, the public data doesn't break down revenue perfectly by each specific customer group you listed, but we know the core business is in the healthcare education space in China. We can map the known financial scale against these required segments.
The company, headquartered in Shanghai, China, is primarily involved in offering educational and training services to healthcare professionals. This is the most clearly defined segment based on available information.
Here is a look at the scale of Zhongchao Inc. (ZCMD) operations as of the latest available figures, which gives you a sense of the overall pool they are serving:
| Metric | Value (as of late 2025/H1 2025) |
| Revenue (Last Twelve Months) | $13.12M |
| Revenue (Half Year Ending June 30, 2025) | $5.60M |
| Annual Revenue (2024) | $15.86M |
| Total Employees | 111 |
| Revenue Per Employee (TTM) | $118,176 |
| Market Capitalization | $15.23M |
The customer segments Zhongchao Inc. (ZCMD) targets, as per your outline, are:
- Healthcare professionals (HCPs) seeking specialized training and education. This group is the confirmed core focus area for the company's services.
- Chronic disease patients, especially those with cancer and SLE.
- Pharmaceutical companies sponsoring educational and patient programs.
- General public seeking reliable health information in China.
For the confirmed segment of HCPs, the revenue generated in the first half of 2025 was part of the total $5.60 million reported for that period. The company's financial position shows a strong balance sheet structure to support these activities, with a Debt / Equity ratio of 0.00 and a Current Ratio of 8.15. This financial stability, despite a net loss of $862,319 in H1 2025, suggests the infrastructure is in place to continue serving its customer base, though growth has been challenging, with 2024 revenue down -18.37% from 2023.
Considering the other potential segments, the pharmaceutical companies would likely be a key source of funding for the educational programs, given the focus on HCP training. The general public segment would likely be reached through information services, which would contribute to the overall revenue base, which was $15.86 million in 2024. The insider ownership stands at 45.20%, indicating a strong alignment between management and the pursuit of these customer segments.
Zhongchao Inc. (ZCMD) - Canvas Business Model: Cost Structure
You're looking at the expense side of Zhongchao Inc.'s operations, and honestly, the numbers show where the pressure points are. The cost structure is heavily weighted toward overhead and the direct costs of running the platform. For the fiscal year ending December 31, 2024, the Sales, General, and Admin (SG&A) expenses were reported at $9.000 million.
Directly tied to service and product delivery, the Cost of Revenue for that same 2024 period stood at $6.953 million. When you put those two major buckets together, you see that operational expenses are substantial relative to the revenue generated in 2024, which was $15.865 million.
Here's a quick look at those key reported costs from the last full fiscal year and the most recent cash flow snapshot:
| Cost Component | Amount (Millions USD) | Period/Date |
| SG&A Expenses | $9.000 | FY 2024 |
| Cost of Revenue | $6.953 | FY 2024 |
| Annual Cash Burn (Approximate) | $4.5 | As of June 2025 |
The cash burn situation is definitely something to watch closely. As of June 2025, the company was burning cash at an approximate rate of $4.5 million annually. What this estimate hides is the volatility; one report noted that the cash burn increased by 475% over the preceding year, which is a defintely concerning trend when operating revenue was simultaneously down 18% over the same period.
A significant, though less granularly reported, cost driver involves content development and platform maintenance, which is central to Zhongchao Inc.'s value proposition, especially with its 'E-Class' intelligent content production platform. For a complex multimedia site like the one Zhongchao operates, you should expect ongoing technology support and content update costs to be material. To give you a frame of reference, general estimates for corporate website maintenance in 2025 can range from $200 to $4,500 per month, not including major development or AI integration costs.
These platform-related expenses fall into several necessary categories:
- Hosting fees, including domain renewals and bandwidth.
- Security patching and compliance updates.
- Costs for AI technology utilization for content generation.
- Developer account fees for app store distribution.
Finance: draft 13-week cash view by Friday.
Zhongchao Inc. (ZCMD) - Canvas Business Model: Revenue Streams
You're looking at the core ways Zhongchao Inc. brings in cash as of late 2025. The picture is one of significant contraction, making the composition of the remaining revenue streams critical for understanding near-term viability.
The primary sources of income for Zhongchao Inc. (ZCMD) center on its digital platform offerings for healthcare professionals. These streams are:
- Service revenue from professional education and patient management.
- Sponsorship fees from pharmaceutical partners for educational projects.
- Product revenue from related medical products.
The overall financial performance for the first half of 2025 shows a steep drop. Total revenue for H1 2025 was reported at $5.6 million, which represents a sharp decline of -46.02% compared to the same period last year. This contraction suggests immediate pressure on all revenue-generating activities.
The product revenue stream is specifically noted as declining in H1 2025, which compounds the overall revenue challenge. Historically, the company's revenue was $15.86 million for the full year 2024.
Here's a quick look at the revenue scale change:
| Period | Total Revenue (USD) | Year-over-Year Change |
| H1 2025 | $5.60 million | -46.02% |
| Full Year 2024 | $15.86 million | -18.37% |
The service revenue, which covers online healthcare information, professional training, and patient management services, remains the backbone of the business. The sponsorship fees from pharmaceutical partners for educational projects are a key component that helps fund the content creation and platform maintenance. If onboarding takes 14+ days, churn risk rises, which would directly impact service revenue quality.
The composition of the revenue streams, based on historical context, generally flows from these activities:
- Fees for professional training and educational services.
- Revenue generated through patient management services.
- Income from related medical product sales, which is currently shrinking.
- Payments from industry partners for project sponsorship.
Finance: draft 13-week cash view by Friday.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.